Top

Clinical and Translational Oncology

Published in:

01-08-2014 | Research Article

Double-strand breaks on F98 glioma rat cells induced by minibeam and broad-beam synchrotron radiation therapy

Authors: S. Gil, Y. Prezado, M. Sabés

Published in: Clinical and Translational Oncology | Issue 8/2014

Abstract

Purpose

To assess the DNA damage induced by MBRT and BB radiations on glioma cells.

Methods

The analysis of fluorescent intensity emitted per nucleus was plotted versus DNA content 2 and 17 h after irradiations. At around cell-doubling time (17 h) after exposures, the remaining DNA radiation damage could be correlated with cellular death.

Results

A higher γH2AX IF intensity per cell could be detected 2 and 17 h after MBRT when compared with BB. 17 h after MBRT, misrepaired damaged cells remained arrested in both G₁ and G₂ phases.

Conclusions

A pronounced G₂ phase arrest was detected at 17 h after MBRT and BB. However, only after MBRT, a dose-dependent increasing number of damaged cells appeared arrested also in the G₁ phase, and a higher amount of cells more prone to undergo apoptosis were detected. The threshold dose required to enhance the effectiveness of both synchrotron radiation techniques was 12 Gy.

Blattmann H, Gebbers JO, Bräuer-Krisch E, Bravin A, Le Duc G, Burkard W, et al. Applications of synchrotron X-rays to radiotherapy. Nucl Instrum Methods Phys Res A. 2005;548:17–22.CrossRef

Curtis HJ. The use of deuteron microbeam for simulating the biological effects of heavy cosmic-ray particles. Radiat Res Suppl. 1967;7:250–7.PubMedCrossRef

Lawrence YR, Li XA, el Naqa I, Hahn CA, Marks LB, Merchant TE, et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys. 2010;76:S20–7.PubMedCentralPubMedCrossRef

Martínez-Rovira I, Sempau J, Fernández-Varea JM, Bravin A, Prezado Y. Monte Carlo dosimetry for forthcoming clinical trials in x-ray microbeam radiation therapy. Phys Med Biol. 2010;55:4375–88.PubMedCrossRef

Dilmanian FA, Button TM, Le Duc G, Zhong N, Pena LA, Smith JAL, et al. Response of rat intracranial 9L gliosarcoma to microbeam radiation therapy. J Neurooncol. 2002;4:26–38.

Serduc R, Christen T, Laissue J, Farion R, Bouchet A, van der Sanden B, et al. Brain tumor vessel response to synchrotron microbeam radiation therapy: a short-term in vivo study. Phys Med Biol. 2008;53:3609–22.PubMedCrossRef

Dilmanian FA, Zhong Z, Bacarian T, Benvenlste H, Romanelli P, Wang R, et al. Interlaced X-ray microplanar beams: a radiosurgery approach with clinical potential. Proc Natl Acad Sci USA. 2006;103:9709–14.PubMedCentralPubMedCrossRef

Prezado Y, Renier M, Bravin A. A new method of creating minibeam patterns for synchrotron radiation therapy: a feasibility study. J Synchrotron Rad. 2009;16:582–6.CrossRef

Prezado Y, Thegumpallil S, Renier M, Bravin A. X-ray energy optimization in minibeam radiation therapy. Med Phys. 2009;36:4897–902.PubMedCrossRef

10.

Gil S, Sarun S, Biete A, Prezado Y, Sabés M. Survival analysis of F98 glioma rat cells following minibeam or broad-beam synchrotron radiation therapy. Rad Oncol. 2011;6:37–46.CrossRef

11.

Rogakou EP, Boon C, Redon C, Bonner WM. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol. 1999;146:905–16.PubMedCentralPubMedCrossRef

12.

Bekker-Jensen S, Lukas C, Kitagawa R, Melander F, Kastan MB, Bartek J, et al. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J Cell Biol. 2006;173:195–206.PubMedCentralPubMedCrossRef

13.

Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol. 2000;10:886–95.PubMedCrossRef

14.

Prezado Y, Martínez-Rovira I, Thegumpallil S, Deman P. Dosimetry protocol for the preclinical trials in white-beam minibeam radiation therapy. Med Phys. 2011;38:5012–9.PubMedCrossRef

15.

Kataoka Y, Bindokas VP, Duggan RC, Murley JS, Grdina DJ. Flow cytometric analysis of phosphorylated histone H2AX following exposure to ionizing radiation in human microvascular endothelial cells. J Radiat Res. 2006;47:245–57.PubMedCrossRef

16.

Van Veelen LR, Cervelli T, van de Rakt MWMM, Theil AF, Essers J, Kanaar R. Analysis of ionizing radiation-induced foci of DNA damage repair proteins. Mutat Res. 2005;574:22–33.PubMedCrossRef

17.

Huang X, Darzynkiewicz Z. Cytometric assessment of histone H2AX phosphorylation: a reporter of DNA damage. Methods Mol Biol. 2006;314:73–80.PubMedCentralPubMedCrossRef

18.

Marková E, Schultz N, Belyaev IY. Kinetics and dose-response of residual 53BP1/γ-H2AX foci. Co-localization, relationship with DSB repair and clonogenic survival. Int J Radiat Biol. 2007;83:319–29.PubMedCrossRef

19.

Mah LJ, Orlowski C, Ververis K, Vasireddy RS, El-Osta A, Karagiannis TC. Evaluation of the efficacy of radiation-modifying compounds using γH2AX as a molecular marker of DNA double-strand breaks. Gen Integr. 2011;2:3–14.CrossRef

20.

Menichetti L, Gaetano L, Zampolli A, Del Turco S, Ferrari C, Bortolussi S, et al. In vitro neutron irradiation of glioma and endothelial cultured cells. S Appl Radiat Isot. 2009;67:S336–40.CrossRef

21.

Jane EP, Pollack IF. Enzastaurin induces H2AX phosphorylation to regulate apoptosis via MAPK signalling in malignant glioma cells. Eur J Cancer. 2010;46:412–9.PubMedCentralPubMedCrossRef

22.

Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. Cytometry in cell necrobiology: analysis of apoptosis and accidental death (necrosis). Cytometry. 1997;27:1–20.PubMedCrossRef

23.

Olive PL, Durand RE. Apoptosis: an indicator of radiosensitivity in vitro? Int J Radiat Biol. 1997;71:695–707.PubMedCrossRef

24.

Dilmanian FA, Qu Y, Feinendegen LE, Peña LA, Bacarian T, Henn FA, et al. Tissue-sparing effect of x-ray microplanar beams particularly in the CNS: is a bystander effect involved? Exp Hematol. 2007;35:69–77.PubMedCrossRef

25.

Zong W-X, Thompson CB. Necrotic death as a cell fate. Genes Dev. 2006;20:1–15.PubMedCrossRef

Title: Double-strand breaks on F98 glioma rat cells induced by minibeam and broad-beam synchrotron radiation therapy
Authors: S. Gil
Y. Prezado
M. Sabés
Publication date: 01-08-2014
Publisher: Springer Milan
Published in: Clinical and Translational Oncology / Issue 8/2014
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-013-1134-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2014

The use of radiotherapy for early breast cancer in woman at different ages

Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis

MYH polyposis syndrome: clinical findings, genetics issues and management

CHD1L is a novel independent prognostic factor for gastric cancer

Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle

Insights into the epithelial mesenchymal transition phenotype in cancer of unknown primary from a global microRNA profiling study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer